# 2025-16852: FDA Calls Public to Shape Pandemic Device Reviews

2025-16852, General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-09-03 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-16852
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-16852
- Title: General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 42588
- Published: 2025-09-03
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Calls Public to Shape Pandemic Device Reviews

## Summary

The FDA is hosting a public meeting with experts to talk about medical devices, especially those used in pandemic preparedness. They want your thoughts too, so they’re opening a public comment period. This affects device makers, healthcare workers, and anyone interested in safer, smarter health tools, with important discussions happening soon and no cost to join in.

## Abstract

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA. In addition, the Committee will meet to discuss and provide advice to FDA on devices used in pandemic preparedness and response to satisfy, in part, a requirement under the Food and Drug Omnibus Reform Act of 2022 (FDORA). The meeting will be open to the public. FDA is establishing a docket for public comment.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-16852 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/03/2025-16852/general-hospital-and-personal-use-devices-panel-of-the-medical-devices-advisory-committee-notice-of)
- [2025-16852 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-03/pdf/2025-16852.pdf)

## Related
- [Previous: 2025-16851, Rescissions Proposals Pursuant to the Congressional Budget and Impoundment Cont…](https://policyrisk.com/federal-register/2025-16851)
- [Next: 2025-16853, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2025-16853)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-16852 (as of 2026-06-08).
